GMP Manufacturing

ABL Europe

ABL Europe SAS is a pure-play GMP CMO, completely dedicated to the provision of viral vector GMP contract manufacturing services, with a particularly strong technical & regulatory track record in process development, scale-up & GMP manufacturing of oncolytic and immunotherapeutic viral vectors, used in all phases of clinical development performed globally.

ABL Europe’s experience provides its clients with:

  • Drug substance, drug product & comprehensive QC testing capabilities in-house
  • Validated aseptic production of non-sterile filterable viral vectors
  • Phase 1 – 3 GMP supply, including pivotal efficacy studies
  • Process development, characterisation and validation
  • Analytical development, qualification and validation
  • CMC section content for phase 1 – 3 clinical trials, including product approval applications

How can we help you?

With addition in 2017 of a brand new 200 L / 500 L SUB facility in Strasbourg and the acquisition of a state-of-the-art 6,500 m2 GMP manufacturing site in Lyon in 2018, ABL’s expansion has further strengthened its position in the GMP viral vector CMO market to support clients with a long term manufacturing strategy able to meet their clinical development & product registration objectives.